CDT Equity Inc. (CDT) Stock
Healthcare · Biotechnology · US
$1.02
+47.19%
Last updated Jun 18, 2026 23:51 UTC
CDT Key Statistics
Market Cap $180,375.78
P/E (TTM) 0.00
P/S (TTM) 0.00
P/B (TTM) 0.00
Revenue (TTM) $2.72B
EPS (TTM) $1,477.50
Dividend Yield —
ROE (TTM) 74.52%
Net Margin 8.75%
Gross Margin 37.98%
52W High $28.75
52W Low $0.67
Analyst View —
Price Target —
Employees 6
Volume 245,049,080
About CDT Equity Inc.
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
CEO: Andrew Regan. Company website
See CDT live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CDT in Terminal
See plans
More Healthcare stocks